netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 30 of 38

Older Oldest

Details
UPD sitematrix Changed from 0 to
20/11/2023 12:43:13
(DavidS )
UPD FurtherInformation Changed from
20/11/2023 12:43:13
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) updated formatting
20/11/2023 12:43:13
(DavidS )
LDL Link Added : NICE TA482: Immunosuppressive therapy for kidney transplant in children and young people : https://www.nice.org.uk/guidance/ta482
06/07/2023 11:40:44
(rpaylor )
LDL Link Added : NICE TA481: Immunosuppressive therapy for kidney transplant in adults : https://www.nice.org.uk/guidance/ta481
06/07/2023 11:40:21
(rpaylor )
LDL Link Added : NICE TA348: Everolimus for preventing organ rejection in liver transplantation : https://www.nice.org.uk/guidance/ta348
06/07/2023 11:40:02
(rpaylor )
LDL Link Added : NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta498
06/07/2023 10:41:40
(rpaylor )
UPD sitematrix Changed from 0 to
17/12/2021 12:30:03
(LoweryM )
UPD FurtherInformation Changed from
17/12/2021 12:30:03
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) formatting
17/12/2021 12:30:03
(LoweryM )
UPD Published from Draft Mode
27/10/2017 15:17:59
(DavidS )
LDL Link Added : NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease : https://www.nice.org.uk/guidance/ta449
26/10/2017 16:19:18
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) NICE TA449
26/10/2017 16:18:50
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) updated
09/08/2017 17:11:38
(DavidS )
UPD Everolimus Published from Draft Mode
26/04/2017 10:25:57
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) updated
26/04/2017 10:09:09
(LoweryM )
LDL Link Added : Clinical Commissioning Policy Statement: Everolimus (Votubia®) for treatment of angiomyolipomas associated with tuberous sclerosis : https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2016/06/b14x09-ps-everolimus-aml.pdf
26/04/2017 10:08:33
(LoweryM )
LDL Link Added : Clinical Commissioning Policy: Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex : https://www.england.nhs.uk/wp-content/uploads/2016/12/clin-comm-pol-16066P.pdf
26/04/2017 09:59:31
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) updated
26/04/2017 09:57:51
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) updated
26/04/2017 09:55:41
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) updated
26/04/2017 09:52:20
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) updated
25/04/2017 13:20:00
(LoweryM )
UPD Everolimus (Afinitor®, Votubia®) Updated NICE TA432
24/04/2017 14:21:48
(DavidS )
LDL Link Added : NICE TA432: Everolimus (Afinitor) for advanced renal cell carcinoma after previous treatment : https://www.nice.org.uk/guidance/ta432
24/04/2017 14:19:36
(DavidS )
LDL Link Added : NICE TA295: Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy : https://www.nice.org.uk/guidance/ta295
20/04/2017 11:59:07
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) additional approved indication by NICE/NHS England
20/04/2017 11:47:51
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) Additional indication approved in line with NHS England Policy
19/04/2017 16:08:27
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) TRAFFIC LIGHT STATUS
24/03/2017 11:29:22
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) TRAFFIC LIGHT STATUS
24/03/2017 11:27:58
(DavidS )
UPD Everolimus (Afinitor®, Votubia®) TRAFFIC LIGHT STATUS
24/03/2017 11:27:38
(DavidS )

 

 
netFormulary